Literature DB >> 27569249

Schizophyllum commune-induced Pulmonary Mycosis.

Qian Shen1, Ya-Ke Yao1, Qing Yang2, Jian-Ying Zhou1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27569249      PMCID: PMC5009606          DOI: 10.4103/0366-6999.189062

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
To the Editor: Schizophyllum commune is a ubiquitous basidiomycetous fungus that commonly colonizes rotting wood.[1] Reports of pulmonary involvement due to S. commune are limited. We herein reported a case of pulmonary mycosis due to S. commune in the First Affiliated Hospital of College of Medicine, Zhejiang University. A 59-year-old Chinese female came to our hospital due to cough and yellow phlegm for 2 months, which was not relieved by anti-inflammatory therapy. The patient stated that she worked in her garden right before her illness. Her previous history included nasal polypectomy. Examination revealed white blood cell count of 6.3 × 109/L with 7.6% of eosinophils, serum carcinoembryonic antigen (CEA) level of 8.1 ng/ml (normal range: 0–5 ng/ml), and high serum IgE levels (883 KU/L). Pulmonary function test did not indicate bronchial asthma. The fractional exhaled nitric oxide (FeNO) level was 65 ppb. Serum biochemistry for renal, hepatic, and blood sugar was unremarkable. Chest computed tomography (CT) showed gloved finger sign, consolidation, and bronchial occlusion of the right middle lobe [Figure 1a]. Bronchoscopic images showed mucosal swelling of the right middle lobe bronchus and mucous plugs in the medial segmental bronchus which could not be removed by forceps and suctioning [Figure 1b]. Biopsy pathology of bronchoscope showed chronic inflammation of mucosa. Brush culture demonstrated filamentous fungus.
Figure 1

(a) Chest computed tomography showed consolidation and bronchial occlusion of the right middle lobe, and high density was seen (white arrow). (b) Bronchoscopic images showed mucosal swelling and mucoid impaction of right middle lobe bronchus. (c) White, woolly colonies of Schizophyllum commune in Sabouraud dextrose agar after incubation. (d) Slide culture of the Schizophyllum commune isolate on malt extract agar, showing hyaline, septate hyphae with clamp connections (black arrow). (e) Large amounts of eosinophils were seen in biopsied tissue. (f) Reexamination of bronchoscopic images was normal. (g) Chest computed tomography showed remarkable absorption of lesion after 50 days of treatment.

(a) Chest computed tomography showed consolidation and bronchial occlusion of the right middle lobe, and high density was seen (white arrow). (b) Bronchoscopic images showed mucosal swelling and mucoid impaction of right middle lobe bronchus. (c) White, woolly colonies of Schizophyllum commune in Sabouraud dextrose agar after incubation. (d) Slide culture of the Schizophyllum commune isolate on malt extract agar, showing hyaline, septate hyphae with clamp connections (black arrow). (e) Large amounts of eosinophils were seen in biopsied tissue. (f) Reexamination of bronchoscopic images was normal. (g) Chest computed tomography showed remarkable absorption of lesion after 50 days of treatment. Endobronchial ultrasound-guided sheath-transbronchial lung biopsy was performed on the patient. Pathologist saw a large amount of eosinophils in biopsied tissue. In Sabouraud dextrose agar, bronchoscopic brush specimen culture grew white and woolly colonies of fungus, and it displayed as annular area in the colonies central [Figure 1c–1e]. Strain identification using nucleotide sequencing (genes for 18S rRNA) demonstrated this fungus as S. commune. The patient was diagnosed as S. commune-induced pulmonary mycosis. The patient was treated with voriconazole and pulmicort inhalation in view of high FeNO level, large amounts of eosinophils in the biopsied tissue, and the isolation of S. commune. After treatment, the patient's symptoms improved significantly. One month after treatment, another bronchoscopy was performed for follow-up, which showed complete resolution of the mucus plugs [Figure 1f]. The FeNO level decreased from 65 ppb to 23 ppb, serum IgE level decreased to 272 KU/L, blood CEA decreased to 5.0 ng/ml, and peripheral blood eosinophils decreased to 0.06 × 109/L. Fifty days after treatment, repeated chest CT scan showed remarkable absorption of the previous lesions [Figure 1g]. Human infection by S. commune was scarcely reported. Previous reports suggested that the incidence might be underestimated because of the difficulties encountered in laboratory identification.[2] The growth form of S. commune is characterized by densely wooly white colonies with a tart smell, formation of basidiocarp after incubation with intermittent sunlight exposure, and concentric annular area in the colonies central. Its microscopic features include septate, branched, hyaline hyphae with clamp connections, spicules, and/or basidiospores.[3] However, molecular techniques are required for definitive identification of S. commune isolate. Regarding treatment, Chowdhary et al.[4] performed in vitro antifungal susceptibility test against S. commune strains, and S. commune was found to have low geometric mean minimal inhibitory concentrations (MICs) of isavuconazole, itraconazole, voriconazole, and amphotericin B, but high geometric mean MICs of fluconazole and flucytosine. From this case, it was learned that S. commune inhalation in an immunocompetent patient might cause eosinophils gathering and mucus formation in the bronchus. It was found that the special morphological and microscopic features of S. commune might help distinguish it from other fungus.

Financial support and sponsorship

This study was supported by a grant from the Scientific Research Program of the Education Department of Zhejiang Province, China (No. Y201223800).

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  The influence of Schizophyllum commune on asthma severity.

Authors:  Haruhiko Ogawa; Masaki Fujimura; Yasuo Takeuchi; Koichi Makimura
Journal:  Lung       Date:  2011-10-18       Impact factor: 2.584

2.  Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Pradeep Kumar Singh; Kshitij Agarwal; Shailendra N Gaur; Pradip Roy; Harbans S Randhawa; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

3.  Nucleotide sequencing for diagnosis of sinusal infection by Schizophyllum commune, an uncommon pathogenic fungus.

Authors:  Olivier Baron; Sophie Cassaing; Josiane Percodani; Antoine Berry; Marie-Denise Linas; Richard Fabre; Elie Serrano; Jean François Magnaval
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 4.  Schizophyllum commune as an emerging fungal pathogen: a review and report of two cases.

Authors:  A Chowdhary; H S Randhawa; S N Gaur; K Agarwal; S Kathuria; P Roy; C H Klaassen; J F Meis
Journal:  Mycoses       Date:  2012-04-23       Impact factor: 4.377

  4 in total
  2 in total

1.  Allergic Bronchopulmonary Mycosis Caused by Schizophyllum commune: A Special Interest in Positive Culture of Other Basidiomycetes Fungi.

Authors:  Akihiko Ito; Takashi Ishiguro; Yotaro Takaku; Naho Kagiyama; Katsuhiko Kamei; Noboru Takayanagi
Journal:  Intern Med       Date:  2019-08-21       Impact factor: 1.271

2.  Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Treated Effectively with Voriconazole.

Authors:  Takashi Ishiguro; Naho Kagiyama; Ayako Kojima; Masami Yamada; Yasuo Nakamoto; Yotaro Takaku; Yoshihiko Shimizu; Kazuyoshi Kurashima; Noboru Takayanagi
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.